Anti-Kallikrein 7 (KLK7); clone 83-1

Code: MABN2430 D2-231

Application

Research CategoryNeuroscience

Anti-Kallikrein 7 (KLK7), clone 83-1, Cat. No. MABN2430, is a highly specific mouse monoclonal antibody that targets Kallikrei...


 Read more

Your Price
€328.00 EACH
€403.44 inc. VAT

Application

Research CategoryNeuroscience

Anti-Kallikrein 7 (KLK7), clone 83-1, Cat. No. MABN2430, is a highly specific mouse monoclonal antibody that targets Kallikrein-7 and has been tested in ELISA and Western Blotting.

ELISA Analysis: A representative lot detected Kallikrein 7 (KLK7) in ELISA applications (Shan, S.J., et. al. (2006). Clin Chem. 52(10):1879-86; Kishi, T., et. al. (2004). Clin Chem. 50(4):709-16).

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

Kallikrein-7 (UniProt: P49862; also known as hK7, KLK7, Serine protease 6, Stratum corneum chymotryptic enzyme, hSCCE) is encoded by the KLK7 (also known as PRSS6, SCCE) gene (Gene ID: 5650) in human. KLK7 is a chymotrypsin-like serine protease of the member of peptidase S1 family. It is synthesized with a signal peptide of 22 amino acids (aa 1-22) and a propeptide region (aa 23-29) that are subsequently cleaved to generate the mature form. Human KLK7 displays about 40 to 60% amino acid homology with other members of the family. It cleaves proteins with aromatic side chains in the P1 position. KLK7 is abundantly expressed in the skin and is also present in the brain, mammary gland, cerebellum, spinal cord, and kidney. Lower levels of expression have been reported in in salivary glands, uterus, thymus, thyroid, placenta, trachea, and testis. Its levels are shown to be up-regulated in ovarian carcinoma, especially late-stage serous carcinoma. Less differentiated tumors of more advanced stage show higher level KLK7 expression. KLK7 activity is inhibited by zinc and copper ions.

Immunogen

Full-length human recombinant Kallikrein-7.

Other Notes

Concentration: Please refer to lot specific datasheet.

Physical form

Format: Purified

Purified mouse monoclonal antibody IgG1 in buffer containing 0.1 M Sodium bicarbonate buffer, pH 8.2 with 0.02% sodium azide.

Quality

Evaluated by Western Blotting in human brain tissue lysate.

Western Blotting Analysis: 0.5 µg/mL of this antibody detected Kallikrein 7 (KLK7) in 10 µg of human brain tissue lysate.

Specificity

Clone 83-1 detects Kallikrein -7 in human tissues.

Storage and Stability

Stable for 1 year at 2-8°C from date of receipt.

Target description

~27 kDa observed; 27.53 kDa calculated. Uncharacterized bands may be observed in some lysate(s).

antibody formpurified immunoglobulin
antibody product typeprimary antibodies
biological sourcemouse
clone83-1, monoclonal
Gene Informationhuman ... KLK7(5650)
isotypeIgG1κ
NCBI accession no.NP_005037
packagingantibody small pack of 25 µg
Quality Level100
species reactivityhuman
technique(s)western blot: suitable, ELISA: suitable
UniProt accession no.P49862
This product has met the following criteria to qualify for the following awards:



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.